Recent clinical reviews have shown that for most patients, starting a GLP-1 medication does not significantly change INR levels
A 2025 preprint study analyzing over 3,000 patients found that women on semaglutide had more than twice the risk of hair loss compared to women on an alternative weight loss medication, while the signal in men was not statistically significant
Our clinics specialize in offering cutting-edge treatments, including semaglutide therapy or tirzepatide therapy, to help you achieve your weight loss goals effectively and sustainably
Hypoglycemia is a recognized risk because IGF-1 has insulin-mimetic properties at the receptor level
Alijani S, Ghadir M, Gargari BP (2024) The association between dietary inflammatory index and dietary total antioxidant capacity and Hashimotos thyroiditis: a case-control study
Jeyachandran S, Chellapandian H, Park K, Kwak I-S